We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. Lipid Manager helps clinicians reduce ASCVD risk by managing patients' LDL-C and ...

Artificial intelligence (AI) and digital technology advances have emerged as catalysts for changing how we diagnose, treat and manage patients. The following collection of AI resources has been ...

ACC's Strategic Plan positions the College and its members for success in achieving the ACC's Mission to transform cardiovascular care and improve heart health for all as cardiovascular disease ...

Learn and stay certified — all in one program: The CMP blends continuous learning with assessment, making it an efficient, effective way to grow your expertise while maintaining your credentials.

The newly released AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (HF) addresses "changes in disease manifestations, diagnostic strategies and understanding of ...

The ACC is dedicated to creating a strong, diverse and inclusive field of future cardiovascular physicians, scientists and professionals. The ACC's Internal Medicine Cardiology and Pediatric Residents ...

Clopidogrel monotherapy was associated with lower risks of major adverse cardiovascular events (MACE) and major bleeding compared with aspirin monotherapy among stable patients post PCI, according to ...

Media registration information for ACC.27/WCC, taking place April 10-12, 2027, in Houston will be available in the fall of 2026.

The Electrophysiology (EP) Section is a vibrant community for all ACC members who are interested in the evaluation and management of heart rhythm disorders. The role of the EP Leadership Council is to ...

The App allows you to search for ACC members by name, city, state or clinical focus. You can also update your own profile and view the latest ACC news right from the ...

The Centers for Medicare and Medicaid Services' (CMS') new Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model will begin July 5, 2026. In preparation for the launch, the agency ...

CMS has proposed ending Coverage with Evidence Development (CED) requirements for patients with symptomatic severe aortic stenosis (AS) while expanding CED to include patients with asymptomatic severe ...